Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Crohn's Disease
  • Age: Between 16 Year(s) - 80 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. Diagnosis of Crohn’s disease (CD) prior to screening using standard endoscopic, histologic, or radiologic criteria
    2. Moderately to severely active Crohn’s disease (CD)
    3. Physician intends to prescribe infliximab as

You may not be eligible for this study if the following are true:

    1. Participants with any of the following CD-related complications:
      • Abdominal or pelvic abscess, including perianal
      • Presence of stoma or ostomy
      • Isolated perianal disease
      • Obstructive disease, su

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.